Tert-butyl 5-[[1-[(3-amino-4-methylphenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate
C25H33N5O2 — CID 90152266
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 5-[[1-[(3-amino-4-methylphenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate
Tert-butyl 5-[[1-[(3-amino-4-methylphenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate (PubChem CID 90152266) has the molecular formula C25H33N5O2 and a molecular weight of 435.57 g/mol. Its IUPAC name is tert-butyl 5-[[1-[(3-amino-4-methylphenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 5-[[1-[(3-amino-4-methylphenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate |
|---|---|
| PubChem CID | 90152266 |
| Molecular Formula | C25H33N5O2 |
| Molecular Weight | 435.57 g/mol |
| Exact Mass | 435.26 |
| IUPAC Name | tert-butyl 5-[[1-[(3-amino-4-methylphenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate |
| SMILES | Cc1ccc(CN2CCCC(Nc3ccc4c(cnn4C(=O)OC(C)(C)C)c3)C2)cc1N |
| InChI | InChI=1S/C25H33N5O2/c1-17-7-8-18(12-22(17)26)15-29-11-5-6-21(16-29)28-20-9-10-23-19(13-20)14-27-30(23)24(31)32-25(2,3)4/h7-10,12-14,21,28H,5-6,11,15-16,26H2,1-4H3 |
| InChIKey | HQDMTHWJVDQLIR-UHFFFAOYSA-N |
| XLogP | 4.79 |
| TPSA | 85.41 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.57 |
| LogP ≤ 5 | 4.79 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90152266 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.